CanSino Shares Jump After WHO Gives Nod to Its Covid-19 Vaccine

What’s new: Shares of CanSino Biologics Inc. (688185.SH) jumped Friday after the World Health Organization gave the company’s single-dose Covid-19 vaccine, Convidecia, approval for emergency use around the world.

CanSino’s shares closed up 12.14% in Shanghai and 9.78% in Hong Kong.

The context: Convidecia is the 11th Covid-19 vaccine to get validated by the WHO, and the third developed by a Chinese company to receive global emergency use approval.